Envoy Medical starts trading on NASDAQ as it tests cochlear implant


On the day of its debut on Nasdaq, the company's stock dropped nearly 30% and trading paused multiple times due to volatility.

Previous Ernst & Young names new managing partner
Next Madrigal Pharmaceuticals completes $500M stock sale as it prepares for potential launch of NASH treatment